Skip to content

Clinical trials

Thrombocytopenia trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Country / region: Germany Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20064
20071
20093
20101
20113
20121
20132
20144
20161
20181
20192
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated7
Active, not recruiting2
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline8
Novartis Pharmaceuticals3
Abbott Medical Devices2
CTI BioPharma2
Eisai Inc.2
Amgen1
Associazione Qol-one1
Bristol-Myers Squibb1
CSL Behring1
Heinrich-Heine University, Duesseldorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia30
Anemia6
Purpura, Thrombocytopenic, Idiopathic6
Hematologic Diseases5
Myelodysplastic Syndromes5
Purpura4
Myeloproliferative Disorders3
Primary Myelofibrosis3
Blood Platelet Disorders2
Bone Marrow Diseases2

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.